Pages that link to "Q70785527"

The following pages link to Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy (Q70785527):

Displaying 18 items.

• Chemotherapy-induced nausea and vomiting: optimizing prevention and management (Q26852601) (← links)
• Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting (Q33571897) (← links)
• Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review (Q34417851) (← links)
• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. (Q36613996) (← links)
• Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients. (Q37355479) (← links)
• Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments (Q37445006) (← links)
• Standard treatment of chemotherapy-induced emesis (Q41332536) (← links)
• Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis (Q43807560) (← links)
• Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT. (Q45988785) (← links)
• A multinational study to measure the value that patients with cancer place on improved emesis control following cisplatin chemotherapy. (Q53463750) (← links)
• Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial. (Q53578107) (← links)
• Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. (Q53602291) (← links)
• An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting (Q57278975) (← links)
• Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis (Q58053733) (← links)
• The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy (Q59647375) (← links)
• Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone (Q73556888) (← links)
• [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research] (Q83944098) (← links)
• Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients (Q92654271) (← links)